fluorodeoxyglucose f18 has been researched along with Pheochromocytoma in 85 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (3.53) | 18.2507 |
2000's | 28 (32.94) | 29.6817 |
2010's | 44 (51.76) | 24.3611 |
2020's | 10 (11.76) | 2.80 |
Authors | Studies |
---|---|
Cottereau, AS; Dousset, B; Garcia, C; Libe, R; Tenenbaum, F | 1 |
Ju, H; Pan, Y; Xu, S; Zhang, Y; Zhou, J | 1 |
Autret, G; Balvay, D; Braik-Djellas, Y; Favier, J; Gimenez-Roqueplo, AP; Lussey-Lepoutre, C; Moog, S; Robidel, E; Salgues, B; Tavitian, B; Viel, T | 1 |
Drubach, L; DuBois, SG; Janeway, KA; Kamihara, J; Krokhmal, AA; Kwatra, N; Voss, SD; Weldon, CB | 1 |
Hahner, S; Hartrampf, PE; Schirbel, A; Werner, RA | 1 |
Abe, T; Hirata, K; Kimura, R; Kudo, K; Shinohara, N; Takenaka, J; Uchiyama, Y; Watanabe, S | 1 |
Marcus, C; Subramaniam, RM | 1 |
Ikeuchi, T; Kikuchi, R; Okuyama, C | 1 |
Cheng, W; Cheng, X; Hou, G; Jiang, Y; Zhu, Z | 1 |
Dong, D; Li, H; Wang, W; Wen, J | 1 |
Huo, L; Jing, H; Li, F; Li, W; Wang, L; Wang, Z; Zhang, J | 1 |
Pacak, K; Taïeb, D | 1 |
Halkar, RK; Moncayo, VM; Pasquel, FJ; Yim, SY | 1 |
El Lakis, M; Gaitanidis, A; Kebebew, E; Merkel, R; Nilubol, N; Nockel, P; Pacak, K; Patel, D; Prodanov, T | 1 |
Ahima, RS; Santhanam, P; Treglia, G | 1 |
El Darazi, E; Goldman, S; Muteganya, R; Tsechelidis, I; Weyts, K | 1 |
Asakura, T; Harada, Y; Katayama, K; Koh, Y; Nishimura, K; Tei, N | 1 |
Cheng, Z; Song, S; Zhu, X; Zou, S | 1 |
Chen, G; Chen, X; Fu, Z; Li, Q | 1 |
Ansquer, C; Drui, D; Kraeber-Bodéré, F; Lugat, A; Mirallié, E | 1 |
Dong, A; Lu, J; Wang, Y; Zuo, C | 1 |
Ahmad, AZ; Donnemiller, E; Fikri, AS; Kendler, D; Kroiss, A; Lau, WF; Nordin, AJ; Uprimny, C; Virgolini, IJ; Zanariah, H | 1 |
Pacak, K; Shulkin, BL; Taïeb, D; Timmers, HJ | 1 |
Demir, T; Gotthardt, M; Hermus, AR; Kunst, DP; Kusters, B; Langenhuijsen, JF; Lenders, JW; Mensenkamp, AR; Oosterwijk, E; Pacak, K; Rao, JU; Sweep, FC; Timmers, HJ; van Berkel, A; van der Laak, JA; Visser, E; Wevers, RA | 1 |
Xie, T; Zaidi, H | 1 |
Bomanji, J; Panagiotidis, E | 1 |
Santhanam, P; Taïeb, D | 1 |
Fukukura, Y; Jinguji, M; Kamimura, K; Nakabeppu, Y; Nakajo, M; Shindo, T; Takumi, K; Yoneyama, T; Yoshiura, T | 1 |
Dieckmann, W; Kebebew, E; Mehta, A; Nilubol, N; Pacak, K; Patel, D | 1 |
Al Ghuzlan, A; Baudin, E; Berdelou, A; Bidault, F; Borget, I; Caramella, C; Déandreis, D; Deschamps, F; Dumont, F; Gimenez-Roqueplo, AP; Guillaud Bataille, M; Hartl, D; Leboulleux, S; Lepoutre-Lussey, C; Lumbroso, J; Nascimento, C; Schlumberger, M | 1 |
Hong, GR; Kim, JJ; Lee, S; Shim, CY; You, SC | 1 |
Kumar, A; Kumar, R; Shamim, SA | 1 |
Angelousi, A; Kaltsas, G; Kassi, E; Zografos, G | 1 |
Brans, B; Gotthardt, M; Havekes, B; Hermus, AR; Lenders, JW; Puar, T; Timmers, HJ; van Berkel, A; van Marken Lichtenbelt, WD; Xu, Y | 1 |
Bhuta, S; Hsu, CC; Kwan, GN; Singh, D | 1 |
Burgess, JR; Kornaczewski, ER; Pointon, OP | 1 |
Jin, J; Li, B; Zhang, M | 1 |
Akhurst, TJ; Chang, CA; Hicks, RJ; Hofman, MS; Kong, G; Pattison, DA; Tothill, RW | 1 |
Charalampopoulos, A; Farrugia, FA; Martikos, G; Misiakos, E; Surgeon, C; Tzanetis, P; Zavras, N | 1 |
Amanuma, M; Arisaka, Y; Endo, K; Higuchi, T; Nakajima, T; Oriuchi, N; Takano, A; Taketomi-Takahashi, A; Tsushima, Y | 1 |
Bergman, J; Kauhanen, S; Korsoff, P; Minn, H; Nuutila, P; Ovaska, J; Salmela, P; Saltevo, J; Sane, T; Seppänen, M; Välimäki, M | 1 |
Guo, CC; Iyer, RB; Perrier, N | 1 |
Barlier, A; Cammilleri, S; De Micco, C; Enjalbert, A; Fakhry, N; Henry, JF; Morange, I; Mundler, O; Niccoli-Sire, P; Palazzo, FF; Sebag, F; Taïeb, D; Tessonnier, L | 1 |
Tenenbaum, F | 1 |
Enomoto, D; Fukuoka, T; Higaki, J; Irita, J; Jotoku, M; Kurata, M; Miyoshi, K; Nagao, T; Okura, T | 1 |
Adams, KT; Carrasquillo, JA; Chen, CC; Eisenhofer, G; Havekes, B; Ling, A; Martiniova, L; Pacak, K; Timmers, HJ; Whatley, M | 1 |
Ayala-Ramirez, M; Callender, GG; Chuang, HH; Goodarzi, M; Jimenez, C; Kupferman, ME; Perrier, ND; Rich, TA; Trent, J | 1 |
Chew, SL | 1 |
Haba, R; Imachi, H; Ishida, T; Kakehi, Y; Kikuchi, F; Kushida, Y; Miyai, Y; Murao, K; Ohyama, T | 1 |
Al Ghuzlan, A; Aupérin, A; Baudin, E; Bidault, F; Deandreis, D; Escourrou, C; Leboulleux, S; Lumbroso, J; Schlumberger, M; Travagli, JP | 1 |
Ayala-Ramirez, M; Chuang, H; Habra, MA; Jimenez, C; Kyle, K; Núñez, R; Rich, T | 1 |
Koroscil, TM; McDonald, S; Stutes, S; Vila, RJ | 1 |
Hirata, Y; Izumiyama, H; Sekizawa, N; Yoshimoto, T | 1 |
Arisaka, Y; Endo, K; Higuchi, T; Nakazawa, A; Oriuchi, N | 1 |
Bernardi, S; Bertolotto, M; De Marchi, S; Fabris, B; Finato, N; Grimaldi, F; Proclemer, A; Sabato, N | 1 |
Amanuma, M; Higuchi, T; Nakano, S; Taketomi-Takahashi, A; Tsushima, Y | 1 |
Chen, L; Cheng, W; Jin, X; Li, F; Zhu, Z; Zhuang, H | 1 |
Joshi, PV; Lele, VR | 1 |
Adams, KT; Carrasquillo, JA; Chen, CC; Eisenhofer, G; King, KS; Ling, A; Pacak, K; Rao, JU; Timmers, HJ; Wesley, RA; Whatley, M | 1 |
Armigliato, M; Casiglia, E; Chondrogiannis, S; Ferretti, A; Marzola, MC; Mazza, A; Rubello, D; Schiavon, L; Tadayyon, S; Zorzan, S | 1 |
Essamet, W; Palazzo, FF; Pauleau, G; Sebag, F; Taïeb, D | 1 |
Caracò, C; Klain, M; Mainolfi, C; Maurea, S; Salvatore, M | 1 |
Fukuchi, K; Hatazawa, J; Ishida, Y; Oku, N; Tatsumi, M; Wahl, RL | 1 |
Bley, TA; Brink, I; Hoegerle, S; Klisch, J | 1 |
Ezuddin, S; Fragkaki, C | 1 |
Guille, J; Haindl, W; Pillai, D; Rossleigh, MA; Sood, R; Story, A | 1 |
Byrd, DR; Kinahan, PE; Krohn, KA; Link, JM; Mankoff, DA; Mann, GN; Pham, P; Pickett, CA | 1 |
Ahlman, H; Bümming, P; Nilsson, B; Nilsson, O; Sörensen, J | 1 |
Avram, AM; Fig, LM; Gross, MD | 1 |
Herts, BR; Remer, EM; Yoon, JK | 1 |
Bui, C; Esfandiari, NH; Jaffe, CA; Shulkin, BL | 1 |
Adams, KT; Carrasquillo, JA; Chen, CC; Eisenhofer, G; Kozupa, A; Lenders, JW; Ling, A; Pacak, K; Solis, D; Timmers, HJ | 1 |
Carrasquillo, JA; Chen, CC; Hadi, M; Pacak, K; Whatley, M | 1 |
Hamazawa, Y; Ikemoto, S; Inoue, Y; Koyama, K; Okamura, T; Ozawa, N; Senzaki, H; Tanabe, S | 1 |
Balan, KK; Brown, MJ; Chatterjee, K; Gurnell, M; Mackenzie, IS; Simpson, H | 1 |
Baroni, RH; Funari, MG; Hidal, JT; Thom, AF; Wagner, J; Yamaga, LY | 1 |
Adams, KT; Carrasquillo, JA; Chen, CC; Eisenhofer, G; Linehan, WM; Ling, A; Pacak, K; Pinto, PA; Timmers, HJ; Whatley, M | 1 |
Adams, KT; Carrasquillo, JA; Chen, CC; Eisenhofer, G; Kozupa, A; Lazúrová, I; Ling, A; Pacak, K; Reynolds, JC; Timmers, HJ; Whatley, MA; Widimsky, J; Zelinka, T | 1 |
Barlier, A; Colavolpe, C; De Micco, C; Henry, JF; Morange, I; Mundler, O; Niccoli-Sire, P; Palazzo, FF; Sebag, F; Taïeb, D; Tessonnier, L | 1 |
Imabayashi, E; Kuji, I; Matsuda, H; Minagawa, A; Miyauchi, T | 1 |
Deeb, GM; Francis, IR; Koeppe, RA; Lloyd, RV; Shulkin, BL; Thompson, NW | 1 |
Dehdashti, F; Moley, JF; Musholt, PB; Musholt, TJ | 1 |
Francis, IR; Shapiro, B; Shulkin, BL; Sisson, JC; Thompson, NW | 1 |
Alavi, A; Yamamoto, AJ; Zhuang, H | 1 |
Hasegawa, S; Iino, K; Ikematsu, Y; Ishizu, K; Kida, H; Nishiwaki, Y; Okawada, T; Ozawa, T; Taniguchi, K; Taniguchi, M; Torizuka, T; Uchimura, M; Waki, S | 1 |
12 review(s) available for fluorodeoxyglucose f18 and Pheochromocytoma
Article | Year |
---|---|
Adrenal functional imaging - which marker for which indication?
Topics: 3-Iodobenzylguanidine; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Biomarkers; Fluorodeoxyglucose F18; Glucose Transport Proteins, Facilitative; Humans; Norepinephrine Plasma Membrane Transport Proteins; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Chemokine; Receptors, Somatostatin | 2022 |
Paragangliomas and Pheochromocytomas: Positron Emission Tomography/Computed Tomography Diagnosis and Therapy.
Topics: Adrenal Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Paraganglioma; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2023 |
New Insights into the Nuclear Imaging Phenotypes of Cluster 1 Pheochromocytoma and Paraganglioma.
Topics: Adrenal Gland Neoplasms; Catecholamines; Fluorodeoxyglucose F18; Humans; Paraganglioma; Phenotype; Pheochromocytoma; Radionuclide Imaging; Receptors, Somatostatin; Stromal Cells; Succinic Acid | 2017 |
Detection of brown adipose tissue by
Topics: Adipose Tissue, Brown; Adrenal Gland Neoplasms; Age Factors; Catecholamines; Female; Fluorodeoxyglucose F18; Humans; Male; Pheochromocytoma; Positron Emission Tomography Computed Tomography | 2018 |
Role of 18F-fluorodeoxyglucose PET in the study of neuroendocrine tumors.
Topics: Adrenal Gland Neoplasms; Carcinoma, Neuroendocrine; Enterochromaffin Cells; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Thyroid Neoplasms | 2014 |
Role of (18) F-FDOPA PET/CT imaging in endocrinology.
Topics: Adrenal Gland Neoplasms; Carbidopa; Carcinoid Tumor; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Dopamine Agents; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2014 |
PET/Computed Tomography in Neuroendocrine Tumor: Value to Patient Management and Survival Outcomes.
Topics: Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gastrointestinal Neoplasms; Humans; Multimodal Imaging; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy; Thyroid Neoplasms; Tomography, X-Ray Computed | 2015 |
Metastatic pheochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Mutation; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Succinate Dehydrogenase; Tomography, X-Ray Computed | 2015 |
Radiology of the adrenal incidentalomas. Review of the literature.
Topics: 3-Iodobenzylguanidine; Addison Disease; Adrenal Cortex Neoplasms; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adrenocortical Carcinoma; Cushing Syndrome; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Hemorrhage; Humans; Hyperaldosteronism; Indium; Indium Radioisotopes; Lymphoma; Magnetic Resonance Imaging; Myelolipoma; Octreotide; Pheochromocytoma; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2017 |
[Adrenal incidentaloma and nuclear medicine examination].
Topics: 19-Iodocholesterol; 3-Iodobenzylguanidine; Adenoma; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adult; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Incidental Findings; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
Imaging of pheochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Adrenal gland scintigraphy.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenal Glands; Cushing Syndrome; Female; Fluorodeoxyglucose F18; Humans; Hyperaldosteronism; Incidental Findings; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ultrasonography; Virilism | 2006 |
3 trial(s) available for fluorodeoxyglucose f18 and Pheochromocytoma
Article | Year |
---|---|
The clinical value of [18F]fluoro-dihydroxyphenylalanine positron emission tomography in primary diagnosis, staging, and restaging of neuroendocrine tumors.
Topics: Adrenal Gland Neoplasms; Adult; Carcinoma, Medullary; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms | 2009 |
Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques.
Topics: 19-Iodocholesterol; 3-Iodobenzylguanidine; Adenoma; Adrenal Gland Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
[11C]metahydroxyephedrine and [18F]fluorodeoxyglucose positron emission tomography improve clinical decision making in suspected pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Ephedrine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pheochromocytoma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Single-Blind Method; Tissue Distribution; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
70 other study(ies) available for fluorodeoxyglucose f18 and Pheochromocytoma
Article | Year |
---|---|
Recurrence of a Pheochromocytoma With TNEM127 Mutation Negative on 18F-FDOPA and 18F-FDG but Positive on 123I-MIBG and 68Ga-DOTATOC Imaging.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Aged; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Mutation; Octreotide; Organometallic Compounds; Pheochromocytoma; Positron Emission Tomography Computed Tomography | 2022 |
Integrated PET/MRI With 68Ga-DOTATATE and 18F-FDG in Pheochromocytomas and Paragangliomas: An Initial Study.
Topics: Adrenal Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Paraganglioma; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radionuclide Imaging; Retrospective Studies | 2022 |
Preclinical evaluation of targeted therapies in Sdhb-mutated tumors.
Topics: Adrenal Gland Neoplasms; Animals; Antineoplastic Agents; Fluorodeoxyglucose F18; Humans; Mice; Mutation; Paraganglioma; Pheochromocytoma; Succinate Dehydrogenase; Succinates; Sunitinib | 2022 |
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Child; Fluorodeoxyglucose F18; Humans; Paraganglioma; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed | 2022 |
Prognostic value of [
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Fluorodeoxyglucose F18; Glycolysis; Humans; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2023 |
FDG Uptake in Brown Adipose Tissue Activated by a β3-Adrenergic Receptor Agonist Prescribed for Overactive Bladder.
Topics: Acetanilides; Adipose Tissue, Brown; Adrenal Gland Neoplasms; Adrenergic Agonists; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles; Urinary Bladder, Overactive | 2020 |
FDG PET/CT Findings in a Patient With Ovarian Metastasis of Pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Pheochromocytoma; Positron Emission Tomography Computed Tomography | 2020 |
A 10-year observational single-center study of retroperitoneal unicentric Castleman disease.
Topics: Adrenal Gland Neoplasms; Adult; Castleman Disease; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Interleukin-6; Lymph Node Excision; Lymph Nodes; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Retroperitoneal Space; Retrospective Studies; Treatment Outcome; Ultrasonography | 2021 |
Comparison of the 68Ga-DOTATATA PET/CT, FDG PET/CT, and MIBG SPECT/CT in the Evaluation of Suspected Primary Pheochromocytomas and Paragangliomas.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Organometallic Compounds; Paraganglioma; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Retrospective Studies; Single Photon Emission Computed Tomography Computed Tomography | 2017 |
Multimodality Radionuclide Imaging in a Patient With Hereditary Paraganglioma-Pheochromocytoma Syndrome.
Topics: Adrenal Gland Neoplasms; Adult; Female; Fluorodeoxyglucose F18; Humans; Paraganglioma; Pheochromocytoma; Positron Emission Tomography Computed Tomography | 2017 |
Preoperative 18F-FDG PET/CT in Pheochromocytomas and Paragangliomas Allows for Precision Surgery.
Topics: Adolescent; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Precision Medicine; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Young Adult | 2019 |
Failure of Classical β-Blocker Carvedilol to Deactivate Brown Adipose Tissue in a Patient With Pheochromocytoma.
Topics: Adipose Tissue, Brown; Adrenal Gland Neoplasms; Adrenergic beta-Antagonists; Adult; Carbazoles; Carvedilol; Female; Fluorodeoxyglucose F18; Humans; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Propanolamines; Treatment Failure | 2018 |
[A Case Report : FDG Uptake to Brown Adipose Tissue Activated by Elevated Serum Catecholamine in a Patient with Pheochromocytoma].
Topics: Adipose Tissue, Brown; Adrenal Gland Neoplasms; Aged; Catecholamines; Female; Fluorodeoxyglucose F18; Humans; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2018 |
Concurrent Metastatic Pheochromocytomas and Lung Adenocarcinoma on 18F-FDG and 68Ga-DOTATATE PET/CT Images.
Topics: Adenocarcinoma of Lung; Adrenal Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Second Primary; Organometallic Compounds; Pheochromocytoma; Positron Emission Tomography Computed Tomography | 2019 |
Bilateral Adrenal Extremely Intense Metabolic Activity on 18F-FDG PET/CT in a Patient With Pheochromocytomas.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pheochromocytoma; Positron Emission Tomography Computed Tomography | 2019 |
18F-FDOPA PET Compared With 123I-Metaiodobenzylguanidine Scintigraphy and 18F-FDG PET in Secreting Sporadic Pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Male; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity; Young Adult | 2019 |
Hypermetabolic mesenteric brown adipose tissue on dual-time point FDG PET/CT in a patient with benign retroperitoneal pheochromocytoma.
Topics: Adipose Tissue, Brown; Adrenal Gland Neoplasms; Adult; Fluorodeoxyglucose F18; Humans; Male; Mesentery; Multimodal Imaging; Pheochromocytoma; Positron-Emission Tomography; Retroperitoneal Neoplasms; Tomography, X-Ray Computed | 2014 |
Localization and prediction of malignant potential in recurrent pheochromocytoma/paraganglioma (PCC/PGL) using 18F-FDG PET/CT.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Predictive Value of Tests; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Renaissance of (18)F-FDG positron emission tomography in the imaging of pheochromocytoma/paraganglioma.
Topics: Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; History, 20th Century; History, 21st Century; Humans; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography | 2014 |
Correlation between in vivo 18F-FDG PET and immunohistochemical markers of glucose uptake and metabolism in pheochromocytoma and paraganglioma.
Topics: Adrenal Gland Neoplasms; Biological Transport; Biomarkers; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose; Glycolysis; Humans; Immunohistochemistry; Male; Middle Aged; Pheochromocytoma; Positron-Emission Tomography | 2014 |
Fetal and maternal absorbed dose estimates for positron-emitting molecular imaging probes.
Topics: Dihydroxyphenylalanine; Female; Fetus; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Pheochromocytoma; Positron-Emission Tomography; Pregnancy; Radiation Dosage | 2014 |
Diagnostic performances of FDG-PET/CT and diffusion-weighted imaging indices for differentiating benign pheochromocytoma from other benign adrenal tumors.
Topics: Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2015 |
Total 18F-FDG PET/CT Metabolic Tumor Volume Is Associated With Postoperative Biochemical Response in Patients With Metastatic Pheochromocytomas and Paragangliomas.
Topics: Adrenal Gland Neoplasms; Adult; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Whole Body Imaging | 2016 |
Screening in asymptomatic SDHx mutation carriers: added value of ¹⁸F-FDG PET/CT at initial diagnosis and 1-year follow-up.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Asymptomatic Diseases; Female; Fluorodeoxyglucose F18; Heterozygote; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Mutation; Pedigree; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Succinate Dehydrogenase; Tomography, X-Ray Computed | 2015 |
Benign primary cardiac neoplasm with intense FDG uptake.
Topics: Coronary Angiography; Female; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Middle Aged; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Genotype-Dependent Brown Adipose Tissue Activation in Patients With Pheochromocytoma and Paraganglioma.
Topics: Adipose Tissue, Brown; Adrenal Gland Neoplasms; Adult; Aged; Catecholamines; Female; Fluorodeoxyglucose F18; Genetic Variation; Genotype; Humans; Male; Middle Aged; Mutation; Paracrine Communication; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
18F-FDG PET/CT in a Patient With Glomus Vagale Paraganglioma and Eisenmenger Syndrome: Searching for the Missing Link?
Topics: Adrenal Gland Neoplasms; Aortic Bodies; Eisenmenger Complex; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Paraganglioma, Extra-Adrenal; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Utility of FDG-PET imaging in screening for succinate dehydrogenase B and D mutation-related lesions.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Retrospective Studies; Succinate Dehydrogenase; Young Adult | 2016 |
Unusual FDG uptakes of mesenteric brown adipose tissue in a patient with pheochromocytomas.
Topics: Adipose Tissue, Brown; Adrenal Gland Neoplasms; Adult; Artifacts; Female; Fluorodeoxyglucose F18; Humans; Mesentery; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tissue Distribution | 2016 |
(68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Organometallic Compounds; Paraganglioma; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2016 |
Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with 18F-FDG positron emission tomography and 123I-MIBG scintigraphy.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Adrenal pheochromocytoma with surrounding brown fat stimulation.
Topics: Adipose Tissue, Brown; Adrenal Gland Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2009 |
18F-FDG avidity of pheochromocytomas and paragangliomas: a new molecular imaging signature?
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Molecular Probe Techniques; Paraganglioma; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Succinate Dehydrogenase; Tissue Distribution | 2009 |
[Case of 131I-meta-iodobenzylguanidine (MIBG) scintigraphy-negative and 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET)-positive pheochromocytoma].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Genotype; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2009 |
Paraganglioma syndrome type 1 in a patient with Carney-Stratakis syndrome.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Carney Complex; Chromogranin A; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Gene Transfer Techniques; Humans; Hypertension; Lymphatic Metastasis; Male; Metanephrine; Mutation; Neck; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Proto-Oncogene Proteins c-kit; Succinate Dehydrogenase; Syndrome; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2010 |
Diagnosis: imaging of pheochromocytomas and paragangliomas.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Contrast Media; Diagnostic Imaging; Dihydroxyphenylalanine; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Positron emission tomography with 18F-fluorodeoxyglucose is a useful tool for the diagnosis of pheochromocytomas without distant metastasis, where malignancy is suspected on the basis of histopathologic analysis.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Aged; Female; Fluorodeoxyglucose F18; Humans; Pheochromocytoma; Positron-Emission Tomography; Tomography, Emission-Computed | 2010 |
Fluorodesoxyglucose uptake in the remaining adrenal glands during the follow-up of patients with adrenocortical carcinoma: do not consider it as malignancy.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocortical Carcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Time Factors | 2011 |
Fatal hypoglycemia in malignant pheochromocytoma: direct glucose consumption as suggested by (18)F-2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging.
Topics: Adrenal Gland Neoplasms; Bone Neoplasms; Disease Progression; Fatal Outcome; Fluorodeoxyglucose F18; Glucose; Humans; Hypoglycemia; Liver Neoplasms; Male; Pheochromocytoma; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon; Tumor Burden; Young Adult | 2010 |
Use of fluorine-18-labelled deoxyglucose positron emission tomography with computed tomography to localize a paraganglioma in pregnancy.
Topics: Adrenal Gland Neoplasms; Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Pregnancy; Pregnancy Complications, Neoplastic; Tomography, X-Ray Computed | 2010 |
Distinct uptake of 18F-fluorodeoxyglucose by brown adipose tissue with a catecholamine-secreting tumor.
Topics: Adipose Tissue, Brown; Adrenal Gland Neoplasms; Catecholamines; Female; Fluorodeoxyglucose F18; Humans; Pheochromocytoma; Radionuclide Imaging; Young Adult | 2010 |
Clinical significance of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography for the assessment of 131I-metaiodobenzylguanidine therapy in malignant phaeochromocytoma.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Biomarkers, Tumor; Catecholamines; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Pheochromocytoma; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
A pheochromocytoma with high adrenocorticotropic hormone and a silent lung nodule.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Cushing Syndrome; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals | 2011 |
Contrast- and non-contrast-enhanced ultrasonography (US) findings of hepatic metastasis from malignant pheochromocytoma/paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2012 |
Intense FDG activity in the brown adipose tissue in omental and mesenteric regions in a patient with malignant pheochromocytoma.
Topics: Adipose Tissue, Brown; Adrenal Gland Neoplasms; Adult; Fluorodeoxyglucose F18; Humans; Male; Mesentery; Multimodal Imaging; Omentum; Pheochromocytoma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Unexpected visitor on FDG PET/CT--brown adipose tissue (BAT) in mesentery in a case of retroperitoneal extra-adrenal pheochromocytoma: is the BAT activation secondary to catecholamine-secreting pheochromocytoma?
Topics: Adipose Tissue, Brown; Adrenal Gland Neoplasms; Adult; Catecholamines; Fluorodeoxyglucose F18; Humans; Male; Mesentery; Multimodal Imaging; Organometallic Compounds; Pheochromocytoma; Positron-Emission Tomography; Retroperitoneal Space; Tomography, X-Ray Computed | 2012 |
Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Gestational diastolic hypertension with gene mutation-related pheochromocytoma positive at ¹⁸F-DOPA PET/CT: diagnostic and therapeutic implications.
Topics: Adrenal Gland Neoplasms; Adult; Diastole; Female; Fluorodeoxyglucose F18; Humans; Hypertension, Pregnancy-Induced; Multimodal Imaging; Mutation; Pheochromocytoma; Positron-Emission Tomography; Pregnancy; Pregnancy Complications, Neoplastic; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Hürthle cell neoplasms: a new differential diagnosis for 18F-FDOPA-avid thyroid nodules?
Topics: Adenoma, Oxyphilic; Adrenal Gland Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Second Primary; Pheochromocytoma; Positron-Emission Tomography; Thyroid Neoplasms; Thyroid Nodule | 2013 |
Radionuclide imaging metabolic activity of brown adipose tissue in a patient with pheochromocytoma.
Topics: Adipose Tissue, Brown; Adolescent; Adrenal Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2004 |
MIBG and FDG PET findings in a patient with malignant pheochromocytoma: a significant discrepancy.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Care Planning; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Superiority of F-18 FDG PET imaging for detection of a pheochromocytoma.
Topics: Adult; Female; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Image Enhancement; Kidney Neoplasms; Neoplasms, Unknown Primary; Pheochromocytoma; Positron-Emission Tomography; Pregnancy; Radiopharmaceuticals | 2006 |
Use of 2-tracer PET to diagnose gastrointestinal stromal tumour and pheochromocytoma in patients with Carney triad and neurofibromatosis type 1.
Topics: Adrenal Gland Neoplasms; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Leiomyoma; Male; Mediastinal Neoplasms; Middle Aged; Neurofibromatosis 1; Paraganglioma, Extra-Adrenal; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
Incidental pheochromocytoma mimicking adrenal adenoma because of rapid contrast enhancement loss.
Topics: Adenocarcinoma; Adenoma; Adrenal Gland Neoplasms; Barrett Esophagus; Contrast Media; Diagnosis, Differential; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Incidental Findings; Magnetic Resonance Imaging; Male; Middle Aged; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Multimodality imaging of malignant pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Image Enhancement; Indium Radioisotopes; Male; Middle Aged; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Dopamine; Female; Fluorodeoxyglucose F18; Germ-Line Mutation; Humans; Iron-Sulfur Proteins; Male; Middle Aged; Neoplasm Metastasis; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Succinate Dehydrogenase | 2007 |
Brown fat imaging with (18)F-6-fluorodopamine PET/CT, (18)F-FDG PET/CT, and (123)I-MIBG SPECT: a study of patients being evaluated for pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adipose Tissue, Brown; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Dopamine; Epinephrine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Norepinephrine; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon | 2007 |
Usefulness of F-18 FDG-PET in a long-term hemodialysis patient with renal cell carcinoma and pheochromocytoma.
Topics: Carcinoma, Renal Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Kidney; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Renal Dialysis; Tomography, X-Ray Computed | 2007 |
The use of 18-fluoro-dihydroxyphenylalanine and 18-fluorodeoxyglucose positron emission tomography scanning in the assessment of metaiodobenzylguanidine-negative phaeochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging | 2007 |
The effect of catecholamines on the glucose uptake in brown adipose tissue demonstrated by (18)F-FDG PET/CT in a patient with adrenal pheochromocytoma.
Topics: Adipose Tissue, Brown; Adrenal Gland Neoplasms; Catecholamines; Diagnosis, Differential; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Usefulness of standardized uptake values for distinguishing adrenal glands with pheochromocytoma from normal adrenal glands by use of 6-18F-fluorodopamine PET.
Topics: Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Iron-Sulfur Proteins; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Prognosis; Radionuclide Imaging; Retrospective Studies; Succinate Dehydrogenase; Tomography, Emission-Computed | 2008 |
The role of 18F-FDOPA and 18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Pheochromocytoma; Positron-Emission Tomography; Retrospective Studies; Tomography, Emission-Computed, Single-Photon | 2008 |
Brown adipose tissue demonstrating intense FDG uptake in a patient with mediastinal pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adipose Tissue, Brown; Adrenal Gland Neoplasms; Adult; Bone Neoplasms; Catecholamines; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypertension; Lymphatic Metastasis; Mediastinal Neoplasms; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Pheochromocytomas that do not accumulate metaiodobenzylguanidine: localization with PET and administration of FDG.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Deoxyglucose; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Iodobenzenes; Pheochromocytoma; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1993 |
Evaluation of fluorodeoxyglucose-positron emission tomographic scanning and its association with glucose transporter expression in medullary thyroid carcinoma and pheochromocytoma: a clinical and molecular study.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Blotting, Western; Carcinoma, Medullary; Child; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 4; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Monosaccharide Transport Proteins; Muscle Proteins; Pheochromocytoma; Positron-Emission Tomography; Thyroid Neoplasms | 1997 |
Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pheochromocytoma; Prognosis; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1999 |
Detection of cranial metastases by F-18 FDG positron emission tomography.
Topics: Adrenal Gland Neoplasms; Adult; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Pheochromocytoma; Radiopharmaceuticals; Skull Neoplasms; Tomography, Emission-Computed | 2001 |
Metastases of predominantly dopamine-secreting phaeochromocytoma that did not accumulate meta-iodobenzylguanidine: imaging with whole body positron emission tomography using 18F-labelled deoxyglucose.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Dopamine; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Palliative Care; Pheochromocytoma; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |